Angiogenesis reflects a balance between stimulating and inhibitory factors,
among which fibroblast growth factor-2 (FGF-2) and vascular endothelial gr
owth factor (VECF) play a central role. FGF-2 stimulates endothelial cell g
rowth and migration and enhances angiogenesis, both in vitro and in vivo. F
GF-2 binds to a specific receptor (FGF R1) at the surface of endothelial ce
lls. In addition to its extracellular effects, FGF-2 exerts intracellular e
ffects that seem to be independent from tyrosine kinase-type receptors. FGF
-2 is produced by several tumor types, including brain tumors, skin tumors,
and fibrosarcomas. FGF-2 may play a pivotal role in angiogenesis in these
tumors.